لابراتوارهای دارویی رازک
درازک | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
-
Last Price: - 0.00
Close Price: -
Balance Sheet
AGM
Interim
2026/07/19 Fiscal Year 2026/03/2012 Month | 2025/06/17 Fiscal Year 2025/03/2012 Month | 2024/07/31 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Cash & Bank Balances | 327.696 Billion | 3.148 Billion | 20.914 Billion | |
Trade Receivables | 20.561 Trillion | 17.953 Trillion | 17.908 Trillion | |
Prepayments | 624.207 Billion | 841.713 Billion | 1.604 Trillion | |
Raw Materials & Packaging Inventory | 4.3 Trillion | 4.034 Trillion | 2.896 Trillion | |
Work-in-Progress Inventory | 386.745 Billion | 376.03 Billion | 401.327 Billion | |
Finished Goods Inventory | 436.586 Billion | 78.382 Billion | 844.972 Billion | |
Spare Parts Inventory | 137.343 Billion | 138.29 Billion | 131.161 Billion | |
Goods in Transit | - | - | 68.407 Billion | |
Our Goods on Consignment with Others | 270.453 Billion | 48.86 Billion | 55.597 Billion | |
Other Inventories | 356.287 Billion | 509.075 Billion | 551.217 Billion | |
Inventories | 5.883 Trillion | 5.178 Trillion | 4.942 Trillion | |
Total Current Assets | 27.396 Trillion | 23.976 Trillion | 24.475 Trillion | |
Long-Term Investments | 247.603 Billion | 1.903 Billion | 1.913 Billion | |
Long-Term Investments in Affiliates | 183.429 Billion | 358.768 Billion | 304.629 Billion | |
Long-Term Trade Receivables | 34.691 Billion | 32.675 Billion | 59.064 Billion | |
Intangible Assets | 50.922 Billion | 58.655 Billion | 57.232 Billion | |
Other Assets | 82.8 Billion | 82.8 Billion | 82.8 Billion | |
Property, Plant & Equipment | 15.781 Trillion | 15.821 Trillion | 565.396 Billion | |
Net Fixed Assets | 15.781 Trillion | 15.821 Trillion | 565.396 Billion | |
Total Non-Current Assets | 16.38 Trillion | 16.356 Trillion | 1.071 Trillion | |
Total Assets | 43.777 Trillion | 40.332 Trillion | 25.546 Trillion | |
Trade Payables | 7.079 Trillion | 6.333 Trillion | 7.758 Trillion | |
Advances Received | 43.98 Billion | 10.384 Billion | 10.384 Billion | |
Income Tax Provision | 1.026 Trillion | 844.31 Billion | 576.131 Billion | |
Other Provisions | 635.259 Billion | 844.767 Billion | 1.547 Trillion | |
Proposed & Payable Dividends | 4.67 Trillion | 5.626 Trillion | 6.269 Trillion | |
Current Borrowings | 5.585 Trillion | 8.27 Trillion | 6.147 Trillion | |
Total Current Liabilities | 19.039 Trillion | 21.929 Trillion | 22.308 Trillion | |
Long-Term Borrowings | 1.542 Trillion | - | - | |
Employee Termination Benefits Provision | 943.952 Billion | 598.725 Billion | 430.272 Billion | |
Total Non-Current Liabilities | 2.485 Trillion | 598.725 Billion | 430.272 Billion | |
Total Liabilities | 21.525 Trillion | 22.527 Trillion | 22.738 Trillion | |
Capital | 17.43 Trillion | 2.1 Trillion | 2.1 Trillion | |
Capital Raise in Progress | - | 15.33 Trillion | - | |
Retained Earnings | 4.59 Trillion | 290.709 Billion | 580.027 Billion | |
Legal Reserve | 436.387 Billion | 210 Billion | 210 Billion | |
Share Premium Reserve | -204.668 Billion | -126.186 Billion | -82.246 Billion | |
Total Equity | 22.252 Trillion | 17.805 Trillion | 2.808 Trillion | |
Total Liabilities & Equity | 43.777 Trillion | 40.332 Trillion | 25.546 Trillion | |
Approved Capital | 17.43 Trillion | 2.1 Trillion | 2.1 Trillion | |
Approved Capital Raise in Progress | - | 15.33 Trillion | - | |
Approved Retained Earnings | 2.847 Trillion | 288.609 Billion | 279.727 Billion | |
Approved Legal Reserve | 436.387 Billion | 210 Billion | 210 Billion | |
Total Approved Equity (at AGM) | 20.713 Trillion | 17.929 Trillion | 2.59 Trillion | |
کالای امانی دیگران نزد ما | 4.55 Billion | 6.018 Billion | 6.018 Billion |